Citigroup
NBP

Citigroup’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Citigroup’s Portfolio NBP Stock Details NBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.25K Sell
2,690
-497
-16% -$1.01K ﹤0.01% 5305
2026
Q1 		$7.84K Sell
3,187
-2,852
-47% -$9.55K ﹤0.01% 5131
2025
Q4 		$24K Sell
6,039
-16,194
-73% -$71.7K ﹤0.01% 4820
2025
Q3 		$84K Buy
22,233
+22,183
+44,366% +$75.3K ﹤0.01% 4327
2025
Q2 		$121 Hold
50
– – ﹤0.01% 5505
2025
Q1 		$41 Hold
50
– – ﹤0.01% 5457
2024
Q4 		$43 Hold
50
– – ﹤0.01% 5720
2024
Q3 		$62 Hold
50
– – ﹤0.01% 5554
2024
Q2 		$84 Hold
50
– – ﹤0.01% 5459
2024
Q1 		$93 Hold
50
– – ﹤0.01% 5500
2023
Q4 		$95 Sell
50
-867
-95% -$1.29K ﹤0.01% 5559
2023
Q3 		$1.21K Sell
917
-23,224
-96% -$51K ﹤0.01% 5066
2023
Q2 		$72.2K Sell
24,141
-28,988
-55% -$93.1K ﹤0.01% 4414
2023
Q1 		$184K Sell
53,129
-2,400
-4% -$11.6K ﹤0.01% 3769
2022
Q4 		$232K Buy
55,529
+38,207
+221% +$145K ﹤0.01% 3643
2022
Q3 		$69K Sell
17,322
-70,526
-80% -$535K ﹤0.01% 4252
2022
Q2 		$993K Buy
87,848
+21,407
+32% +$257K ﹤0.01% 2655
2022
Q1 		$1.08M Buy
66,441
+44,264
+200% +$1.13M ﹤0.01% 2890
2021
Q4 		$1.05M Buy
22,177
+1,260
+6% +$75.6K ﹤0.01% 3204
2021
Q3 		$1.52M Buy
20,917
+1,502
+8% +$109K ﹤0.01% 2756
2021
Q2 		$1.63M Sell
19,415
-12,622
-39% -$833K ﹤0.01% 2836
2021
Q1 		$1.55M Buy
32,037
+11,048
+53% +$599K ﹤0.01% 2661
2020
Q4 		$990K Buy
+20,989
New +$826K ﹤0.01% 3550

Other funds holding NBP

HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
ACM
AIHC Capital Management Central $104M AUM
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $22.2B AUM 58.34% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Citigroup's NBP Position: Q2 2026 in Review

Citigroup reduced its NovaBridge Biosciences American Depositary Shares (NBP) stake by 16% in Q2 2026, selling an estimated $1.01K and leaving 2,690 shares worth $5.25K. The position accounts for ﹤0.01% of the portfolio, ranked #5305.

Citigroup first reported a position in NBP in Q4 2020 and has held it in 23 quarters since. The position peaked at $1.63M in Q2 2021. 49 funds tracked by Wall St. Rank hold NBP as of Q2 2026.

  • Citigroup held 2,690 shares of NovaBridge Biosciences American Depositary Shares worth $5.25K as of Q2 2026.
  • Citigroup sold 497 NovaBridge Biosciences American Depositary Shares shares in Q2 2026, an estimated $1.01K.
  • NovaBridge Biosciences American Depositary Shares made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #5305 holding.
  • Citigroup first reported a position in NovaBridge Biosciences American Depositary Shares in Q4 2020 and has held it in 23 quarters since.
  • Citigroup's NovaBridge Biosciences American Depositary Shares position peaked at $1.63M in Q2 2021.
  • 49 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.